ScholarIQanswers from OpenAlex & ORCID
Amanda N. Fader
ResearcherPublications, citations & collaboration network
Amanda N. Fader is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Amanda N. Fader have?
ScholarIQindexed works
Amanda N. Fader has 378 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Amanda N. Fader have?
ScholarIQcitation count
Amanda N. Fader has 22,629 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Amanda N. Fader?
ScholarIQh-index
Amanda N. Fader has an h-index of 67 in OpenAlex.
What is the i10-index of Amanda N. Fader?
ScholarIQi10-index
Amanda N. Fader has an i10-index of 174 in OpenAlex.
What is the ORCID of Amanda N. Fader?
ScholarIQorcid
The ORCID for Amanda N. Fader is on the source record.
What is the OpenAlex record for Amanda N. Fader?
ScholarIQopenalex
The OpenAlex for Amanda N. Fader is on the source record.
What are the most-cited papers on Amanda N. Fader?
ScholarIQmost cited works
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Dung T. Le, Jennifer N. Durham, Kellie N. Smith, Hao Wang, Bjarne R. Bartlett, Laveet K. Aulakh, Steve Lu, Holly Kemberling, Cara Wilt, Brandon Luber, Fay Wong, Nilofer S. Azad, Agnieszka A. Rucki, Dan Laheru, Ross C. Donehower, Atif Zaheer, George A. Fisher, Todd S. Crocenzi, James J. Lee, Tim F. Greten, Austin G. Duffy, Kristen K. Ciombor, Aleksandra Eyring, Bao H. Lam, Andrew K. Joe, Soonmo Peter Kang, Matthias Holdhoff, Ludmila Danilova, Leslie Cope, Christian F. Meyer, Shibin Zhou, Richard M. Goldberg, Deborah K. Armstrong, Katherine M. Bever, Amanda N. Fader, Janis M. Taube, Franck Housseau, David Spetzler, Nianqing Xiao, Drew M. Pardoll, Nickolas Papadopoulos, Kenneth W. Kinzler, James R. Eshleman, Bert Vogelstein, Robert A. Anders, Luis A. Díaz
Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer
Ramez N. Eskander, Michael W. Sill, Lindsey Beffa, Richard G. Moore, Joanie M. Hope, Fernanda Musa, Robert S. Mannel, Mark S. Shahin, Guilherme Cantuaria, Eugenia Girda, Cara Mathews, Juraj Kavecansky, Charles A. Leath, Lilian T. Gien, Emily Hinchcliff, Shashikant Lele, Lisa M. Landrum, Floor Backes, Roisin E. O’Cearbhaill, Tareq Al Baghdadi, Emily K. Hill, Premal H. Thaker, Veena S. John, Stephen Welch, Amanda N. Fader, Matthew A. Powell, Carol Aghajanian
Randomized Phase II Trial of Carboplatin-Paclitaxel Versus Carboplatin-Paclitaxel-Trastuzumab in Uterine Serous Carcinomas That Overexpress Human Epidermal Growth Factor Receptor 2/neu
Amanda N. Fader, Dana M. Roque, Eric R. Siegel, Natália Buza, Pei Hui, Osama Abdelghany, Setsuko K. Chambers, Angeles Alvarez Secord, Laura J. Havrilesky, David M. O’Malley, Floor Backes, Nicole Nevadunsky, Babak Edraki, Dirk Pikaart, William J. Lowery, Karim ElSahwi, Paul Celano, Stefania Bellone, Masoud Azodi, Babak Litkouhi, Elena Ratner, Dan‐Arin Silasi, Peter E. Schwartz, Alessandro D. Santin
Uterine Neoplasms, Version 1.2014
Wui-Jin Koh, Benjamin E. Greer, Nadeem R. Abu‐Rustum, Sachin M. Apte, Susana M. Campos, John K. Chan, Kathleen R. Cho, David E. Cohn, Marta A. Crispens, Nefertiti C. duPont, Patricia J. Eifel, Amanda N. Fader, Christine M. Fisher, David K. Gaffney, Suzanne George, Ernest Han, Warner K. Huh, John R. Lurain, Lainie P. Martin, David G. Mutch, Steven W. Remmenga, R. Kevin Reynolds, William Small, Nelson N.H. Teng, Todd Tillmanns, Fidel A. Valea, Nicole R. McMillian, Miranda Hughes